Manufacturing, R&D, and clinical trials are all important, but pricing is just as crucial. Making the domestic market more difficult to access puts Belgium in a…
In Conversation
As an industry, we have a responsibility to collect information on reported outcomes and work with health authorities to ensure our products are doing what we…
Our state-of-the-art R&D capabilities and history of successful translation of good science into numerous spin-offs and winners have put us at the forefront of the global…
My goal is to introduce the proven Japanese standard in dialysis treatment to Europe. By adopting their practices, we can make a profound impact, drastically extending…
It is time to act and realise the critical importance of the healthcare sector both from a medical and an economic perspective
BMS has been able to deliver for Belgian patients and physicians, in partnership with the health minister and his team
With the strains on healthcare budgets across the world, the reallocation, repurposing, and reuse of existing resources stand to have just as big an impact on…
At the core of our business is generics and, as part of that, day-one launches are all important
Belgium, if we compare it to other countries in Europe, is a real pharmaceutical hub, and for this, I would like to thank the authorities. We…
If you see the impact of our medicines on people's lives and their families, such as with our Parkinson's Disease medicines, it drives you to continue…
Simplifying procedures and adapting to changing times is essential
We are optimising internal and external processes while investing in three irreversible forces driving the future of healthcare: advancing smart connected care, enabling new care settings…
